Lijuan Zhang — University of Massachusetts Chan Medical School

Area of research

Epidemiology · Molecular Biology

Research interest

Research focused on Autophagy and Cancer research, with related work in Hepatic stellate cell, Nephropathy, Docetaxel. Notable publications include 'Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment', 'Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway', and 'Risk of mother-to-child transmission after amniocentesis in pregnant women with hepatitis B virus: a retrospective cohort study'.

Recent publications

Exploring macrophage heterogeneity in IgA nephropathy: Mechanisms of renal impairment and current therapeutic targets

International Immunopharmacology 2024cited by 9position: middledoi

Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway

Phytomedicine 2023cited by 40position: middledoi

Risk of mother-to-child transmission after amniocentesis in pregnant women with hepatitis B virus: a retrospective cohort study

American Journal of Obstetrics and Gynecology 2023cited by 12position: middledoi

Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment

Journal of Controlled Release 2017cited by 100position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Epidemiology · Molecular Biology →